Back to search

Article

Blood<i>N</i>-glycomic signature of fibrosis in MASLD shows low levels of global α2,3-sialylation

2024-09-22

Abstract excerpt

<h4>Background & Aims</h4> Alterations in the glycosylation of blood proteins affect protein functionality and have been linked to various diseases. Metabolic dysfunction- associated steatotic liver disease (MASLD) is a silent disease, of which progression to advanced disease stages including metabolic dysfunction-associated steatohepatitis (MASH), fibrosis and cirrhosis often goes unnoticed. As current non- invas...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
a01c465e-4896-50ec-89f0-e3247ba8130d
DOI
10.1101/2024.09.19.24313949
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Blood<i>N</i>-glycomic signature of fibrosis in MASLD shows low levels of global α2,3-sialylationDOI 10.1101/2024.09.19.24313949
Select a neighboring publication to make it the new centre.